Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC02523 (Long intergenic non-protein coding RNA 2523) is a long non-coding RNA gene in humans, classified as a lincRNA. Such transcripts are present in intergenic regions—DNA stretches between protein-coding genes—and do not encode proteins[5][3]. Generally, lincRNAs are implicated in gene regulation, epigenetic modification, and control of chromatin structure[3][7], although for LINC02523 itself, specific biological or disease associations are not established and its function remains poorly characterized in the literature. No drugs or biomarkers are associated with this transcript, and it is not recognized as a traditional therapeutic target[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2523 (LINC02523).